SE0403171D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0403171D0
SE0403171D0 SE0403171A SE0403171A SE0403171D0 SE 0403171 D0 SE0403171 D0 SE 0403171D0 SE 0403171 A SE0403171 A SE 0403171A SE 0403171 A SE0403171 A SE 0403171A SE 0403171 D0 SE0403171 D0 SE 0403171D0
Authority
SE
Sweden
Prior art keywords
compounds
new compounds
preparation
new
salts
Prior art date
Application number
SE0403171A
Other languages
English (en)
Inventor
Miroslaw Tomaszewski
Simon Woo
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0403171A priority Critical patent/SE0403171D0/sv
Publication of SE0403171D0 publication Critical patent/SE0403171D0/sv
Priority to EP05821044A priority patent/EP1833834A1/en
Priority to JP2007548159A priority patent/JP2008525434A/ja
Priority to CNA2005800486080A priority patent/CN101128470A/zh
Priority to PCT/SE2005/002020 priority patent/WO2006068618A1/en
Priority to US11/721,637 priority patent/US20080306107A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
SE0403171A 2004-12-23 2004-12-23 New compounds SE0403171D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0403171A SE0403171D0 (sv) 2004-12-23 2004-12-23 New compounds
EP05821044A EP1833834A1 (en) 2004-12-23 2005-12-22 New compounds
JP2007548159A JP2008525434A (ja) 2004-12-23 2005-12-22 新規な化合物
CNA2005800486080A CN101128470A (zh) 2004-12-23 2005-12-22 新化合物
PCT/SE2005/002020 WO2006068618A1 (en) 2004-12-23 2005-12-22 New compounds
US11/721,637 US20080306107A1 (en) 2004-12-23 2005-12-22 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0403171A SE0403171D0 (sv) 2004-12-23 2004-12-23 New compounds

Publications (1)

Publication Number Publication Date
SE0403171D0 true SE0403171D0 (sv) 2004-12-23

Family

ID=34102119

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0403171A SE0403171D0 (sv) 2004-12-23 2004-12-23 New compounds

Country Status (6)

Country Link
US (1) US20080306107A1 (sv)
EP (1) EP1833834A1 (sv)
JP (1) JP2008525434A (sv)
CN (1) CN101128470A (sv)
SE (1) SE0403171D0 (sv)
WO (1) WO2006068618A1 (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
WO2010099166A1 (en) 2009-02-27 2010-09-02 Siga Technologies, Inc. Thienopyridine derivatives for the treatment and prevention of dengue virus infections
US20130129677A1 (en) * 2009-02-27 2013-05-23 Siga Technologies, Inc. Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
US20120295942A1 (en) 2010-02-01 2012-11-22 Nicholas James Devereux Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
ES2527849T3 (es) 2010-02-02 2015-01-30 Novartis Ag Derivados de ciclohexilamida como antagonistas del receptor de CRF
JPWO2013187462A1 (ja) 2012-06-14 2016-02-08 第一三共株式会社 ピペリジニルピラゾロピリジン誘導体
WO2014089378A1 (en) * 2012-12-07 2014-06-12 Siga Technologies, Inc. Thienopyridine derivatives for the treatment and prevention of dengue virus infections
JP2016506929A (ja) * 2013-01-23 2016-03-07 ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago ヒト銅輸送タンパク質atox1およびccsを阻害するための方法および組成物
WO2017107089A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor
ES2789756T3 (es) 2015-12-23 2020-10-26 Merck Sharp & Dohme Moduladores alostéricos de 6,7-dihidro-5H-pirrolo[3,4-b]piridin-5-ona del receptor de acetilcolina muscarínico M4
CN109071560B (zh) * 2016-02-12 2022-01-14 瓦洛健康公司 用作泛素特异性蛋白酶抑制剂的噻吩并吡啶甲酰胺
ES2763274T3 (es) 2016-02-12 2020-05-27 Forma Therapeutics Inc Carboxamidas de tienopirazina como inhibidores de la proteasa específica de la ubiquitina
WO2018112842A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor
WO2018112840A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
CA3065309A1 (en) 2017-06-01 2018-12-06 Bristol-Myers Squibb Company Substituted nitrogen containing compounds
WO2019000236A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000237A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000238A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019032863A1 (en) 2017-08-11 2019-02-14 Forma Therapeutics, Inc. CARBOXAMIDES USED AS UBIQUITIN SPECIFIC PROTEASE INHIBITORS
CN111909181B (zh) * 2019-05-09 2023-02-07 杭州普济远成生物医药科技有限公司 一类泛素化特异性蛋白酶抑制剂及其制备方法与应用
CA3191163A1 (en) * 2020-08-10 2022-02-17 Dana-Farber Cancer Institute, Inc. Fused tricyclic pyrimidine-thieno-pyridine small molecule inhibitors of ubiquitin-specific protease 28

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506767A (en) * 1965-08-06 1970-04-14 Geigy Chem Corp Benzimidazole compositions and methods of use
US3711608A (en) * 1971-04-13 1973-01-16 Merck & Co Inc The treatment of pain, fever and inflammation with benzimidazoles
US4239887A (en) * 1979-10-31 1980-12-16 Usv Pharmaceutical Corporation Pyridothienotriazines
DD247002A1 (de) * 1986-02-26 1987-06-24 Univ Leipzig Verfahren zur herstellung substituierter n-alkyl (bzw. aryl)-(3-amino-thieno/2,3-b/pyridin)-2-carbonsaeureamide
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
WO1992003427A1 (en) * 1990-08-17 1992-03-05 Yoshitomi Pharmaceutical Industries, Ltd. Ketone compound and remedy for osteoporosis
WO1993013664A2 (en) * 1992-01-11 1993-07-22 Schering Agrochemicals Limited Biheterocyclic fungicidal compounds
DE4237617A1 (de) * 1992-11-06 1994-05-11 Bayer Ag Verwendung von substituierten Benzimidazolen
GB9424379D0 (en) * 1994-12-02 1995-01-18 Agrevo Uk Ltd Fungicides
AU2001277731A1 (en) * 2000-08-09 2002-02-18 Welfide Corporation Fused bicyclic amide compounds and medicinal use thereof
US6974870B2 (en) * 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
DE60329513D1 (de) * 2002-07-30 2009-11-12 Banyu Pharma Co Ltd Antagonist des melanin-concentrating-hormone-rezeptors, enthaltend ein benzimidazolderivat als wirkstoff
AR045979A1 (es) * 2003-04-28 2005-11-23 Astrazeneca Ab Amidas heterociclicas
RU2241002C1 (ru) * 2003-07-24 2004-11-27 Кубанский государственный технологический университет 1,2,3,4-тетрагидропиридо[3',2':4,5]тиено[3,2-d]пиримидин-4-оны-антидоты гербицида гормонального действия 2,4-дихлорфеноксиуксусной кислоты

Also Published As

Publication number Publication date
CN101128470A (zh) 2008-02-20
WO2006068618A1 (en) 2006-06-29
US20080306107A1 (en) 2008-12-11
EP1833834A1 (en) 2007-09-19
JP2008525434A (ja) 2008-07-17

Similar Documents

Publication Publication Date Title
SE0403171D0 (sv) New compounds
UA85576C2 (ru) Тетразольные соединения и их применение в качестве метаботропических антагонистов рецепторов глутамата
TW200716529A (en) New compounds II
SE0202133D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
TW200508207A (en) New benzimidazole derivatives
SE0301700D0 (sv) Novel compounds
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
TW200745122A (en) New compounds I
TW200801003A (en) Novel compounds
SE0302811D0 (sv) Novel compounds
UA96277C2 (en) Benzimidazole derivatives
SE0302139D0 (sv) Novel compounds
TW200833670A (en) Novel compounds 569
SE0401762D0 (sv) Novel compounds
TW200740781A (en) Novel compounds
TW200512201A (en) New heterocyclic amides
SE0303541D0 (sv) New compounds
PL376324A1 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
MX2007003119A (es) Nuevas amidas heterociclicas.
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
TW200730512A (en) Novel compounds
SE0302546D0 (sv) New compounds
TW200720262A (en) Novel compounds ii